Bellicum Reports First Quarter 2020 Financial Results and Provides Operational Update  

NEXT STORY
Coherus BioSciences Reports First Quarter 2020 Financial Results
PREV STORY
Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kaleido Biosciences Announces Presentation of Data for Microbiome Metabolic Therapy KB174 for Hepatic Encephalopathy at The Digital International Liver Congress™ (EASL)

author_avatar
NASDAQ Market News

Stemline Therapeutics Announces Date Change for the Company’s Presentation at the 35th Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today ...

author_avatar
NASDAQ Market News

AB Science issues a corrective press release regarding adverse events information from study AB09004 reported on December 16, 2020

author_avatar
NASDAQ Market News